Morgans Under the Microscope
Morgans Financial Limited
Add to My Podcasts
Episodes
About
Reviews
Promote
Under the microscope: Cochlear (ASX:COH) - Derek Jellinek, Senior Analyst
5 minutes
Posted Jul 6, 2020 at 12:50 am.
0:00
5:27
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Cochlear (COH) gains FDA’s blessing on multiple products, but nothing appears game-changing.
Previous
Under the microscope: Imagion Biosystems (ASX:IBX) - Robert Proulx, Chief Executive Officer
Next
Under the microscope: Mach7 Technologies (ASX:M7T) - Scott Power, Senior Analyst
← See all 96 episodes of Morgans Under the Microscope
